| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |